| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/23/1999 | US5874104 Treatment of systemic fungal infections with phospholipid particles encapsulating polyene antibiotics |
| 02/23/1999 | US5874103 Dosage consists of an ionophore antibiotic, wetting agent or surfactant, antifreeze agent, suspension agent and water; orally administered to an animal to treat ketosis and/or bloat; enhancement of milk and milk protein |
| 02/23/1999 | US5874100 Alginate fibres, manufacture and use |
| 02/23/1999 | US5874099 Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core |
| 02/23/1999 | US5874098 Sustained release implant antibiotic for cattle |
| 02/23/1999 | US5874095 Pharmaceutical active material, non-ionic crosslinked polyacrylamide having a molecular weight of from 1,000,000 to 30,000,000, the polyacrylamide being predispersed in a water-immiscible oil containing a surfactant |
| 02/23/1999 | US5874092 Comprising a surfactant-free blend of a lipophilic component and a hydrophilic component; homogenizing using a mixer-extruder; cosmetics; skin and hair care |
| 02/23/1999 | US5874090 Sustained-release formulation of methylphenidate |
| 02/23/1999 | US5874086 Synthetic polypeptide analogs of parathyroid hormone (pth), parathyroid hormone related peptide (pthrp), and of the physiologically active truncated homologs and analogs of pth and pthrp; forming an amphipathic alpha-helix |
| 02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |
| 02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
| 02/23/1999 | US5874075 Stable protein: phospholipid compositions and methods |
| 02/23/1999 | US5874074 Film-forming lotion for topical administration comprising an oil in-water emulsion consisting of water, polyhydric alcohol, water-soluble film-forming barrier polymer, oil phase, therapeutic agent; treatment of acne, psoriasis |
| 02/23/1999 | US5874064 Aerodynamically light particles for pulmonary drug delivery |
| 02/23/1999 | US5874063 Pharmaceutical formulation |
| 02/23/1999 | US5874029 Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
| 02/23/1999 | US5873359 Methods and devices for treating pulmonary vasoconstriction and asthma |
| 02/23/1999 | US5873358 Inhaling |
| 02/23/1999 | CA2149653C Methods and compositions for dispensing fragrances |
| 02/21/1999 | CA2245314A1 Method for removal of residual organic solvents and use thereof in maufacturing pharmaceuticals |
| 02/20/1999 | CA2213385A1 Method of protecting against coccidiosis infections in poultry |
| 02/18/1999 | WO1999007714A1 Phosphocholines of retinoids |
| 02/18/1999 | WO1999007463A1 Method for releasing an active principle contained in a multiple emulsion |
| 02/18/1999 | WO1999007418A2 Sterile bioerodible implant device with improved biocompatability and method |
| 02/18/1999 | WO1999007417A1 Hemostatic tissue sealants |
| 02/18/1999 | WO1999007416A1 TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS |
| 02/18/1999 | WO1999007415A1 Administrable compositions and methods for magnetic resonance imaging |
| 02/18/1999 | WO1999007370A1 Oral solid pharmaceutical compositions containing nicorandil for a modulated release and the process for their preparation |
| 02/18/1999 | WO1999007365A1 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 02/18/1999 | WO1999007362A1 A PROCESS FOR STABIlIZING LEVOGYRE ASCORBIC ACID (LAA) AND STABLE LAA COMPOSITIONS |
| 02/18/1999 | WO1999007355A1 Idebenone-containing preparation for percutaneous administration |
| 02/18/1999 | WO1999007349A2 Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin |
| 02/18/1999 | WO1999007348A1 Gelatin spray coating |
| 02/18/1999 | WO1999007347A1 Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules |
| 02/18/1999 | WO1999007346A1 Implantable gas propelled beneficial agent delivery device |
| 02/18/1999 | WO1999007345A1 Film coating with salts |
| 02/18/1999 | WO1999007344A1 Powdery aerosol preparation |
| 02/18/1999 | WO1999007343A1 Injectable biodegradable block copolymer gels for use in drug delivery |
| 02/18/1999 | WO1999007342A1 Prolonged release active agent dosage form adapted for gastric retention |
| 02/18/1999 | WO1999007341A1 Compositions for nasal administration |
| 02/18/1999 | WO1999007340A1 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 02/18/1999 | WO1999007237A1 Composition comprising a liquid absorbed on a support based on precipitate silica |
| 02/18/1999 | WO1999007224A1 Compositions and methods for treating diabetes |
| 02/18/1999 | WO1998051348A3 Sustained-release delayed gels |
| 02/18/1999 | WO1998051279A3 Method of making microencapsulated dna for vaccination and gene therapy |
| 02/18/1999 | DE19733651A1 Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole Aqueous aerosol formulations containing biologically active molecules Marko and method for generating appropriate aerosols |
| 02/18/1999 | DE19732866A1 Soya extract containing group B soya saponin(s) |
| 02/18/1999 | DE19732855A1 Soya extract containing group B soya saponin(s) |
| 02/18/1999 | CA2303273A1 Gelatin spray coating |
| 02/18/1999 | CA2302410A1 Film coating with salts |
| 02/18/1999 | CA2299711A1 Powdery aerosol preparation |
| 02/18/1999 | CA2299393A1 Injectable biodegradable block copolymer gels for use in drug delivery |
| 02/18/1999 | CA2299336A1 Hemostatic tissue sealants |
| 02/18/1999 | CA2299298A1 Compositions for nasal administration |
| 02/18/1999 | CA2298442A1 Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin |
| 02/18/1999 | CA2297174A1 Aqueous aerosol preparations containing biologically active macromolecules and process for producing the corresponding aerosols |
| 02/18/1999 | CA2268030A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions |
| 02/17/1999 | EP0896825A1 Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors |
| 02/17/1999 | EP0896823A1 Improved stabilization of prostaglandin drug |
| 02/17/1999 | EP0896821A1 A novel pharmaceutical composition for inhalation containing CR 2039 (andolast) |
| 02/17/1999 | EP0896820A1 Ophthalmic composition comprising naloxone and at least one polyhydric alcohol |
| 02/17/1999 | EP0896818A1 Improved rapidly disintegratable multiparticulate tablet |
| 02/17/1999 | EP0896817A1 A zinc containing oral preparation and a procell for preparing it |
| 02/17/1999 | EP0896816A1 Liposome and liposome dispersion |
| 02/17/1999 | EP0896815A1 Suspension of sparingly water-soluble acidic drug |
| 02/17/1999 | EP0896603A1 Polymer powders redispersible in aqueous solution |
| 02/17/1999 | EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS |
| 02/17/1999 | EP0896541A1 Silver-based pharmaceutical compositions |
| 02/17/1999 | EP0896534A1 Injection formulations of avermectins and milbemycins based on castor oil |
| 02/17/1999 | EP0896530A1 Dosage forms and uses |
| 02/17/1999 | EP0896529A1 Estradiol and progesterone-based medicament |
| 02/17/1999 | EP0896528A2 Polyol composition |
| 02/17/1999 | EP0896527A1 Pharmaceutical compositions for the sustained release of insoluble active principles |
| 02/17/1999 | EP0896526A1 Agglomerates containing beta-lactam compounds |
| 02/17/1999 | EP0896525A1 Methods of dry powder inhalation |
| 02/17/1999 | EP0784506B1 Method of coating particles |
| 02/17/1999 | EP0633774B1 Topical administration of toremifene and its metabolites |
| 02/17/1999 | CN1208350A High-content famciclovir tablets |
| 02/17/1999 | CN1208348A Method for treating pain |
| 02/17/1999 | CN1208345A Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 02/17/1999 | CN1208344A Patch carrying a particulate material and a magnet |
| 02/17/1999 | CN1208343A Gastrointestinal drug delivery system |
| 02/17/1999 | CN1208338A Composition and method for acceleration of wound and burn healing |
| 02/17/1999 | CN1208043A Crystalline progestagens |
| 02/17/1999 | CN1207943A Hepatitis curing capsule |
| 02/17/1999 | CN1207938A Kaochangxinbuhuang capsule (powder) for psychentonia of examinee and its preparation |
| 02/17/1999 | CN1207933A Compound process of specific ointment treating tinea pedis and eczema |
| 02/17/1999 | CN1207932A Menalgia plaster |
| 02/17/1999 | CN1207931A Hyperosteogeny plaster |
| 02/17/1999 | CN1207930A Rheumatism plaster |
| 02/17/1999 | CN1207928A Traumatic injury plaster |
| 02/17/1999 | CN1207927A Plaster for periarthritis of shoulder joint |
| 02/17/1999 | CN1207926A Gastrosis plaster |
| 02/17/1999 | CN1207925A Blood pressure depressing Yongquan plaster |
| 02/17/1999 | CN1207921A Quick acting Chinese medicine for various headaches and its preparation |
| 02/17/1999 | CN1207898A Simethicone/anhydrous calcium phosphate compositions |
| 02/17/1999 | CN1207896A Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/17/1999 | CN1207895A Clarithromycin capsule |
| 02/17/1999 | CN1207894A Preparation of medicine troche with lubricating coating |
| 02/17/1999 | CN1042132C 8-amino-10-(azabicycloalkyl)-pyrido (1,2,3-D,E) (1,3,4) benzoxadiazine derivatives |